Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
NCT ID: NCT03872544
Last Updated: 2022-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
20 participants
OBSERVATIONAL
2023-09-20
2025-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
NCT03880188
Autologous Fat Transfer for Scar Prevention and Remodeling
NCT01119326
Feasibility Study - The Place of Surgical Management by Fatty Autograft in Patients With Healed Pelvic Eschar. Interest in Secondary Prevention.
NCT03669406
Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device
NCT01924364
Autologous Point-of-Care Adipose Therapy: Recent Injury
NCT06857448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of wound contracture, breakdown of overlying tissue, or challenging anatomical deformities
* Patient has had two or more failed reconstructive attempts or has failed two or more attempts to treat local infection
* Speak, read, and understand English
* Willing to freely give consent
* Is able or has a legal representative to give consent
Exclusion Criteria
* Absence of wound contracture, breakdown of overlying tissue, or challenging aesthetic deformities
* Patient has not had two or more failed reconstructive attempts or has not failed two or more attempts to treat local infection
* Does not speak, read, or understand English
* Unwilling to freely give consent
* Is unable or does not have a legal representative to give consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dufresne, Craig, MD, PC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Craig R Dufresne, MD
Role: PRINCIPAL_INVESTIGATOR
Dr Craig R Dufresne, MD, PC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Office of Craig R Dufresne, MD, PC
Fairfax, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Dufresne CR, Poling MI. Free Dermal Fat Autografting for Complex Craniofacial Wounds. J Craniofac Surg. 2020 Sep;31(6):1563-1567. doi: 10.1097/SCS.0000000000006398.
Dufresne CR, Poling MI. Free Dermal Fat Autografts for Complex Craniofacial Wounds: A 3-decade, Retrospective Cohort Study. PRS Global Open. 2019 August; 7(8S-1):101. doi: 10.1097/01.GOX.0000584800.01063.18.
Related Links
Access external resources that provide additional context or updates about the study.
Principal Investigator's (Dr Craig R Dufresne) Research and Press Relations main webpage. Last Accessed: 7 Jun 2022
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000088
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1229-8480
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.